Schedule 13G ownership disclosure

CHROMOCELL THERAPEUTICS CORP

Security class unavailable · CUSIP: 171126105

Event date: 2024-02-21

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
444,070
Percent of class
7.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001753926-24-000447
Form type
SC 13G
Filer
Aperture Healthcare Ventures Ltd.
CIK
CIK 2000037
Filed
Mar 01, 2024
Reporting period
Feb 21, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub